Mauro Niso

Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer

Amalia Azzariti, Nicola Antonio Colabufo, Francesco Berardi et al. · Molecular Cancer Therapeutics · 2006 · 113 citations · Full text

Breast Oncology, Low Sigma, Chemoprevention Strategy +19

Antiproliferative and cytotoxic effects of some ?2 agonists and ?1 antagonists in tumour cell lines

NicolaAntonio Colabufo, Francesco Berardi, Marialessandra Contino et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 109 citations

Cytotoxic Effects, Tumour Cell Lines, Chemoprevention Strategy +10

Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives

Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore et al. · Bioorganic & Medicinal Chemistry · 2007 · 80 citations · Full text

Medicinal Chemistry, Natural Sciences, Organic Chemistry +4

Structure−Affinity Relationship Study on<i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-Piperazinealkylamides, a New Class of 5-Hydroxytryptamine₇Receptor Agents

Marcello Leopoldo, Francesco Berardi, Nicola Antonio Colabufo et al. · Journal of Medicinal Chemistry · 2004 · 67 citations · Full text

Molecular Pharmacology, Drug Target, Biochemistry +13

Elements in support of the ‘non-identity’ of the PGRMC1 protein with the σ2 receptor

Carmen Abate, Mauro Niso, Vittoria Infantino et al. · European Journal of Pharmacology · 2015 · 64 citations · Full text

Protein Function, Molecular Physiology, Signal Transduction +12